Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Grutters

Showing results (91-100 of 259) with videos related to

Pageof 26
Sort By:
Plos One|February 1, 2012
Association between variations in cell cycle genes and idiopathic pulmonary fibrosisNicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 12, 2012
Diagnostic pathways for interstitial lung diseases in primary careMarianne J Heins, Tjard R J Schermer, Marleen E A de Saegher, et al.
Expert Review of Respiratory Medicine|January 6, 2018
Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?Bart De Brouwer, Ianthe Piscaer, Jan H Von Der Thusen, et al.
The European Respiratory Journal|January 23, 2016
⁹⁹mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosisRoeland Vis, Gaurav Malviya, Alberto Signore, et al.
The European Respiratory Journal|August 31, 2013
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosisAdriane D M Vorselaars, Anouk Verwoerd, Coline H M van Moorsel, et al.
Respiratory Medicine|August 26, 2021
Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseasesYu-Hsiang Chiu, Julia Spierings, Pim A de Jong, et al.
Respirology (Carlton, Vic.)|December 25, 2015
Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumoniasJoanne J van der Vis, Reinier Snetselaar, Karin M Kazemier, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 4, 2022
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of ExcellenceRobert P Baughman, Jan C Grutters, Athol U Wells, et al.
International Journal of Molecular Sciences|December 9, 2023
New Insights via RNA Profiling of Formalin-Fixed Paraffin-Embedded Lung Tissue of Pulmonary Fibrosis PatientsDymph Klay, Karin M Kazemier, Joanne J van der Vis, et al.
Chest|July 22, 2008
Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosisMichiel Heron, Jan C Grutters, Heleen van Velzen-Blad, et al.
Pageof 26

Showing results (91-100 of 259) with videos related to

Sort By:
Pageof 26
Plos One|February 1, 2012
Association between variations in cell cycle genes and idiopathic pulmonary fibrosisNicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 12, 2012
Diagnostic pathways for interstitial lung diseases in primary careMarianne J Heins, Tjard R J Schermer, Marleen E A de Saegher, et al.
Expert Review of Respiratory Medicine|January 6, 2018
Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?Bart De Brouwer, Ianthe Piscaer, Jan H Von Der Thusen, et al.
The European Respiratory Journal|January 23, 2016
⁹⁹mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosisRoeland Vis, Gaurav Malviya, Alberto Signore, et al.
The European Respiratory Journal|August 31, 2013
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosisAdriane D M Vorselaars, Anouk Verwoerd, Coline H M van Moorsel, et al.
Respiratory Medicine|August 26, 2021
Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseasesYu-Hsiang Chiu, Julia Spierings, Pim A de Jong, et al.
Respirology (Carlton, Vic.)|December 25, 2015
Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumoniasJoanne J van der Vis, Reinier Snetselaar, Karin M Kazemier, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 4, 2022
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of ExcellenceRobert P Baughman, Jan C Grutters, Athol U Wells, et al.
International Journal of Molecular Sciences|December 9, 2023
New Insights via RNA Profiling of Formalin-Fixed Paraffin-Embedded Lung Tissue of Pulmonary Fibrosis PatientsDymph Klay, Karin M Kazemier, Joanne J van der Vis, et al.
Chest|July 22, 2008
Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosisMichiel Heron, Jan C Grutters, Heleen van Velzen-Blad, et al.
Pageof 26